AlphaCentric Advisors LLC

SEC CIK: 0001913464
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2026): 9,426
Value: $737.8K
% of portfolio: 0.6%
Quarters held: 3; Since Q4 2025

Holdings of HALO by AlphaCentric Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	9,426	$737.8K	0.6%	+4,632+96.6%	Added	Holders
Q1 2026	4,794	$309.8K	0.3%	+261+5.8%	Added	Holders
Q4 2025	4,533	$305.1K	0.3%	–	No prior filing	Holders